MeSH tree: C19.246.300
Sleeping for 7 hours and 18 minutes every night may be the sweet spot for warding off the risk of insulin resistance—the precursor to type 2 diabetes—suggests a large observational study published in the open access journal ...
4 hours ago
0
0
A tooth cavity and bleeding gums is a common scenario among Danish children—and one that researchers now connect to health problems long after the last baby tooth has left the mouth. Children who have multiple tooth cavities ...
Mar 2, 2026
0
0
The month of Ramadan, which began last week, is when many Muslims around the world fast from dawn to sunset, refraining from food, drink, and other physical needs as an act of worship and self-discipline.
Mar 1, 2026
0
0
Metabolic dysfunction, rather than steatotic liver disease (SLD), seems to be the main driver of chronic kidney disease (CKD) risk, according to research published online Feb. 23 in Nutrition & Diabetes.
Feb 27, 2026
0
0
Participants in a New Zealand e-bike pilot program say cycling has improved their physical and mental health and helped in managing chronic conditions such as diabetes and asthma, a study from the University of Otago, Wellington–Ōtākou ...
Feb 27, 2026
0
3
Human metabolism is regulated by internal clocks, the so-called circadian rhythms. Many processes, such as sugar uptake, fat burning, or hormone release, oscillate during the day, i.e., they fluctuate and exhibit characteristic ...
Feb 26, 2026
0
0
An international clinical trial has found that an oral form of semaglutide, a widely used diabetes drug, reduced the risk of serious heart failure events in people with type 2 diabetes who already had heart failure. The findings, ...
Feb 26, 2026
0
0
A new Danish study compiles 10 years of research from one of the world's largest and most detailed puberty cohorts and points to three main conclusions: puberty is occurring earlier; genes, pregnancy and family life all play ...
Feb 26, 2026
0
0
A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a year than the current available oral GLP-1 RA (semaglutide), finds a phase 3 randomized controlled trial ...
Feb 26, 2026
0
0
Individuals living with type 2 diabetes (T2D) had a significantly lower risk of poor cardiovascular health when they used a GLP-1 receptor agonist (GLP-1 RA) in combination with adhering to healthy lifestyle habits, according ...
Feb 25, 2026
0
0
